This website uses cookies. For more information please contact us or consult our privacy policy.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
- Home
- News and Insights
- Insights
- USDA Releases Questions for Input on the National Bioengineered Disclosure Standard Proposed Rule
USDA Releases Questions for Input on the National Bioengineered Disclosure Standard Proposed Rule
June 28, 2017, Covington Alert
Today, USDA’s Agricultural Marketing Service (AMS) released 30 questions to gather input from stakeholders that it will use in drafting a proposed rule as required by The National Bioengineered Food Disclosure Standard enacted last year on July 29, 2016 (click here for Covington’s client alert). By statute, AMS has two years--until July 29, 2018--to establish a national disclosure standard and the procedures necessary to implement the standard.
January 5, 2017, Covington Alert
Yesterday, FDA issued a long-anticipated draft guidance intended to help industry comply with the agency’s May 2016 final rules modernizing nutrition labeling. Presented in a question-and-answer format, the draft guidance (Q&A Draft Guidance) provides information related to the compliance date, labeling of added sugars, rounding of the declaration of quantitative amounts of vitamins and minerals, and label format. Notably, it does not address the issue of dietary fiber, which FDA defined for the first time in the new nutrition labeling regulations. Nor does it extend the current earliest compliance deadline of July 26, 2018.
November 2, 2016, Covington Alert
Last week, FDA released a draft guidance1 clarifying requirements for the “disclosure statement” provisions of its four major Food Safety Modernization Act (FSMA) rules. Entities subject to these provisions must disclose, in documents accompanying the food, that certain hazards have not been controlled. The draft guidance provides insight into the circumstances in which FDA would expect covered entities to utilize the “disclosure statement” provisions, explains how the covered entity should describe the identified hazard, and discusses what type of documents may be used for the disclosure statement. Additionally, FDA reminds industry stakeholders that the entity receiving such a disclosure statement is responsible for taking appropriate steps to ensure that the identified hazards are controlled before the food reaches the consumer.
August 25, 2016
Earlier this week, FDA released five chapters of a multi-chapter draft guidance on hazard analysis and risk-based preventive controls for human food. The long-awaited draft guidance is intended to help industry comply with certain requirements of the agency’s final rule for preventive controls for human food (PC rule) under the Food Safety Modernization Act (FSMA). The PC rule generally requires all FDA-registered domestic and foreign food facilities to establish and implement a food safety system, documented in a written food safety plan that is prepared by a preventive controls qualified individual (PCQI) and includes an analysis of hazards and implementation of risk-based preventive controls (PCs).